Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Moodys
McKesson
Merck
Colorcon

Last Updated: August 17, 2022

Us Antibiotics Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the competitive landscape for US ANTIBIOTICS, and what generic and branded alternatives to US ANTIBIOTICS drugs are available?

US ANTIBIOTICS has fifteen approved drugs.



Summary for Us Antibiotics
US Patents:0
Tradenames:11
Ingredients:3
NDAs:15

Drugs and US Patents for Us Antibiotics

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Antibiotics AUGMENTIN '200' amoxicillin; clavulanate potassium FOR SUSPENSION;ORAL 050725-001 May 31, 1996 DISCN Yes No See Plans and Pricing See Plans and Pricing
Us Antibiotics AUGMENTIN '125' amoxicillin; clavulanate potassium TABLET, CHEWABLE;ORAL 050597-001 Jul 22, 1985 DISCN Yes No See Plans and Pricing See Plans and Pricing
Us Antibiotics AMOXIL amoxicillin FOR SUSPENSION;ORAL 062226-002 Approved Prior to Jan 1, 1982 AB RX No No See Plans and Pricing See Plans and Pricing
Us Antibiotics AUGMENTIN '400' amoxicillin; clavulanate potassium TABLET, CHEWABLE;ORAL 050726-002 May 31, 1996 DISCN Yes No See Plans and Pricing See Plans and Pricing
Us Antibiotics LEVOCETIRIZINE DIHYDROCHLORIDE levocetirizine dihydrochloride TABLET;ORAL 204323-001 Dec 20, 2016 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Us Antibiotics

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 6,746,692 See Plans and Pricing
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 6,878,386 See Plans and Pricing
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 6,783,773 See Plans and Pricing
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 7,217,430 See Plans and Pricing
Us Antibiotics AUGMENTIN XR amoxicillin; clavulanate potassium TABLET, EXTENDED RELEASE;ORAL 050785-001 Sep 25, 2002 7,250,176 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for US ANTIBIOTICS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Tablets 1000 mg/62.5 mg ➤ Subscribe 2009-01-21
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Colorcon
Baxter
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.